Metabolomics & Pharmacology

Pharmacogenomics has some impact in clinical practice, through its use to select patient subgroups who will enjoy efficacy without side effects when treated with certain drugs. However, pharmacogenomics, has had less impact than initially predicted. One reason for this is that many diseases, and the way in which the patients respond to drug treatments, have both genetic and environmental elements. Pure genomics is almost blind to the environmental elements. A new methodology has emerged, termed pharmacometabolomics that is concerned with the prediction of drug effects through the analysis of pre-dose, biofluid metabolite profiles, which reflect both genetic and environmental influences on human physiology. 

  • Implications of Clinical Pharmacology
  • Pharmaceutical research & Metabolomics in the New born

Related Conference of Metabolomics & Pharmacology

March 23-24, 2020

World Congress on Biosensors and Bioelectronics

Osaka, Japan
April 16-17, 2020

16th World Congress on Structural Biology

Amsterdam, Netherlands
April 20-21, 2020

11th Tissue Science and Regeneration Congress

Kualalumpur, Malaysia
June 28-30 2020

globalbiotechnology-cs-2020

June 28-30 2020

oilgas-cs-2020

June 28-30 2020

BEHAVIOURAL SCIENCE-2020

June 28-30 2020

Bioinfo 2020

May 10-11, 2020

26th World Nursing & Nurse Practitioner Conference

Yokohama, Japan
July 17-18, 2020

10th Glycobiology World Congress

Vienna, Austria
August 4-5, 2020

12th Euro Biosensors & Bioelectronics Congress

Zurich, Switzerland
September 28-29, 2020

2nd International Conference on Metabolomics, Genomics and Proteomics

Singapore City, Singapore
September 28-29, 2020

19th International Conference on Structural Biology

Barcelona, Spain
October 08-09, 2020

10th European Biosimilars Summit

Milan, Italy
October 14-15, 2020

9th World Congress on Glycobiology & Glycochemistry

Rome, Italy

Metabolomics & Pharmacology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in